First Derivatives and BGF form strategic partnership
First Derivatives plc (FD) has agreed a partnership with BGF. The partnership, aimed at developing companies, will combine access to FD’s technology and support with access to BGF’s £2.5bn balance sheet and network of board level executives. The aim is to turn bright ideas into disruptive companies in some of the most exciting sectors of the economy.
Over the course of the last year FD has received increasing numbers of requests from established, start-up and scale up firms as well as researchers and incubators at academic institutions interested in understanding how Kx – FD’s ultra-high performance technology platform for the processing of real-time, streaming and historical data – could help them solve problems, build a business or even unlock entirely new markets.
These companies, working in areas as diverse as smart meters, personalised medicine, genome research and the interpretation of satellite data, have helped underscore the relevance of Kx to markets far removed from the financial services arena, where Kx has established a market-leading position.
In financial services, FD’s Kx technology, which analyses vast amounts of data and provides real-time insight to those analysing that data, has delivered orders-of-magnitude improvements across the capital markets and counts 19 of the top 20 global investment banks as customers.
Recognising the potential for Kx to disrupt markets beyond financial services, FD has already made moves to apply the technology to companies in the digital marketing, retail analytics and utilities sectors. Now, as an extension of those efforts, the partnership enables FD and BGF to support the growth of some of Britain’s most innovative, exciting technology businesses: advising, assisting and investing in those firms as they adopt Kx technology to achieve their ambitions. Target areas include cyber security, AI, blockchain, robotics, nanotechnology, life sciences, neurology and machine learning.
Under the terms of the partnership, FD and BGF will work together to assess opportunities and support the growth of successful applicant companies. FD will provide resources and operational expertise for product innovation and development, while BGF will provide access to its extensive balance sheet and support network. The partnership will further extend BGF’s reach into earlier stage businesses, following the launch of BGF Ventures in 2015.
Founded by Brian Conlon in 1996, FD has become one of Europe’s most prominent tech success stories, and one of the most successful companies on AIM since the launch of the market.
BGF provided £387m in funding to UK smaller and mid-sized companies in 2016, up from £257m the previous year, making the last 12 months its most successful to date.
Stephen Welton, CEO of BGF said: “Taking a proven technology that has successfully disrupted one market and developing this for other markets is innovation in its truest sense.
“FD is a fantastic story of entrepreneurial success. The aim of this partnership is to create a multiplier effect around the Kx technology and support the growth of more businesses by providing access to knowledge, people and funding in a commercially sustainable way.”
Brian Conlon, founder and CEO of FD: “We have long since recognised the power and scalability of Kx. Having transformed areas of the financial markets, we are extremely excited about working with entrepreneurs, scientists, creatives and technologists in other fields to apply the technology into new areas.”
“This is our first strategic partnership with an investment company. We wanted a patient partner that could provide long-term funding so that earlier stage innovations have the opportunity to reach their full potential. We share BGF’s passion for supporting the growth of British businesses, and are delighted to be working with them.”
For further information, please visit www.firstderivatives.com/fundingforgrowth
Business funding news
BGF welcomes successful exit of Brindley Healthcare
BGF has welcomed the successful acquisition of a 50% shareholding in Brindley Healthcare by French multinational Orpea, a leading European…
BGF to become cornerstone investor in Calnex Solutions’ IPO
BGF has today announced that it is investing in Calnex Solutions plc, an established provider of test and measurement solutions…